Report of Foreign Issuer (6-k)

---

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

REPORT OF FOREIGN ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of

The Securities Exchange Act of 1934 

 

For the month of July 2014

 

PACIFIC THERAPEUTICS LTD.

---

(Translation of registrant’s name into English)

 

409 Granville Street, Suite #1500

Vancouver, BC, V6C-1T2 Canada

Tel: [phone]

Fax: [phone]

---

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x     Form 40-F o

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes o No x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

 

 

 

 

 

 

 

 

 

 

 

 

1

---

 

 

 

SUBMITTED HEREWITH

 

 

Exhibits

 

99.1	News Release dated July 17, 2014

 

 

 

2

---

 

    

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: July 22, 2014

 

 

	PACIFIC THERAPEUTICS LTD
	By:	/s/ Douglas H. Unwin
	Name:	Douglas H. Unwin
	Title:	CEO

 

 

 

 

 

 

 

 

 

 

 

 

 

3

---